Antimicrobial Agents and Chemotherapy, October 2004, p. 3892-3904, Vol. 48, No. 10
0066-4804/04/$08.00+0 DOI: 10.1128/AAC.48.10.3892-3904.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.
VanD-Type Vancomycin-Resistant Enterococcus faecium and Enterococcus faecalis
Florence Depardieu,1 Mathias Kolbert,1,
Hendrik Pruul,2 Jan Bell,3 and Patrice Courvalin1*
Unité des Agents Antibactériens, Institut Pasteur, Paris, France,1
Flinders Medical Centre, Adelaide,2
Department of Infectious Diseases, Women's and Children's Hospital, North Adelaide, Australia3
Received 24 February 2004/
Returned for modification 19 April 2004/
Accepted 13 May 2004
Enterococcus faecium clinical isolates A902 and BM4538, which were resistant to relatively high levels of vancomycin (128 and 64 µg/ml, respectively) and to low levels of teicoplanin (4 µg/ml), and Enterococcus faecalis clinical isolates BM4539 and BM4540, which were resistant to moderate levels of vancomycin (16 µg/ml) and susceptible to teicoplanin (0.25 µg/ml), were studied. They were constitutively resistant by synthesis of peptidoglycan precursors ending with D-alanyl-D-lactate and harbored a chromosomal vanD gene cluster which was not transferable by conjugation to other enterococci. VanXD activity, which is not required in the absence of D-Ala-D-Ala, was low in the four strains, although none of the conserved residues was mutated; and the constitutive VanYD activity in the membrane fractions was inhibited by penicillin G. The mutations E13G in the region of D-alanine:D-alanine ligase (which is implicated in D-Ala1 binding in A902) and S319N of the serine involved in ATP binding in BM4538 and a 7-bp insertion at different locations in BM4539 and BM4540 (which led to putative truncated proteins) led to the production of an impaired enzyme and accounted for the lack of D-Ala-D-Ala-containing peptidoglycan precursors. The same 7-bp insertion in vanSD of BM4539 and BM4540 and a 1-bp deletion in vanSD of A902, which in each case led to a putative truncated and presumably nonfunctional protein, could account for the constitutive resistance. Strain BM4538, with a functional VanSD, had a G140E mutation in VanRD that could be responsible for constitutive glycopeptide resistance. This would represent the first example of constitutive van gene expression due to a mutation in the structural gene for a VanR transcriptional activator. Study of these four additional strains that could be distinguished on the basis of their various assortments of mutations confirmed that all VanD-type strains isolated so far have mutations in the ddl housekeeping gene and in the acquired vanSD or vanRD gene that lead to constitutive resistance to vancomycin.
* Corresponding author. Mailing address: Unité des Agents Antibactériens, Institut Pasteur, 25, rue du Docteur Roux, 75724 Paris Cedex 15, France. Phone: (33) (1) 45 68 83 21. Fax: (33) (1) 45 68 83 19. E-mail: pcourval{at}pasteur.fr.
Present address: Mathias Kolbert, Bioscientia, 55218 Ingelheim, Germany.
Antimicrobial Agents and Chemotherapy, October 2004, p. 3892-3904, Vol. 48, No. 10
0066-4804/04/$08.00+0 DOI: 10.1128/AAC.48.10.3892-3904.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Domingo, M.-C., Huletsky, A., Giroux, R., Picard, F. J., Bergeron, M. G.
(2007). vanD and vanG-Like Gene Clusters in a Ruminococcus Species Isolated from Human Bowel Flora. Antimicrob. Agents Chemother.
51: 4111-4117
[Abstract]
[Full Text]
-
Rea, M. C., Clayton, E., O'Connor, P. M., Shanahan, F., Kiely, B., Ross, R. P., Hill, C.
(2007). Antimicrobial activity of lacticin 3147 against clinical Clostridium difficile strains. J Med Microbiol
56: 940-946
[Abstract]
[Full Text]
-
Beltrametti, F., Consolandi, A., Carrano, L., Bagatin, F., Rossi, R., Leoni, L., Zennaro, E., Selva, E., Marinelli, F.
(2007). Resistance to Glycopeptide Antibiotics in the Teicoplanin Producer Is Mediated by van Gene Homologue Expression Directing the Synthesis of a Modified Cell Wall Peptidoglycan. Antimicrob. Agents Chemother.
51: 1135-1141
[Abstract]
[Full Text]
-
Depardieu, F., Podglajen, I., Leclercq, R., Collatz, E., Courvalin, P.
(2007). Modes and Modulations of Antibiotic Resistance Gene Expression. Clin. Microbiol. Rev.
20: 79-114
[Abstract]
[Full Text]
-
Tanimoto, K., Nomura, T., Maruyama, H., Tomita, H., Shibata, N., Arakawa, Y., Ike, Y.
(2006). First VanD-Type Vancomycin-Resistant Enterococcus raffinosus Isolate. Antimicrob. Agents Chemother.
50: 3966-3967
[Full Text]
-
Camargo, I. L. B. C., Dalla Costa, L. M., Woodford, N., Gilmore, M. S., Darini, A. L. C.
(2006). Sequence Analysis of Enterococcus faecium Strain 10/96A (VanD4), the Original Vancomycin-Resistant E. faecium Strain in Brazil.. J. Clin. Microbiol.
44: 2635-2637
[Abstract]
[Full Text]
-
Boyd, D. A., Miller, M. A., Mulvey, M. R.
(2006). Enterococcus gallinarum N04-0414 Harbors a VanD-Type Vancomycin Resistance Operon and Does Not Contain a D-Alanine:D-Alanine 2 (ddl2) Gene. Antimicrob. Agents Chemother.
50: 1067-1070
[Abstract]
[Full Text]
-
Lavigne, J.-P., Marchandin, H., Bouziges, N., Sotto, A.
(2005). First Infection with VanD-Type Glycopeptide-Resistant Enterococcus faecium in Europe. J. Clin. Microbiol.
43: 3512-3515
[Abstract]
[Full Text]
-
Depardieu, F., Perichon, B., Courvalin, P.
(2004). Detection of the van Alphabet and Identification of Enterococci and Staphylococci at the Species Level by Multiplex PCR. J. Clin. Microbiol.
42: 5857-5860
[Abstract]
[Full Text]
Copyright © 2004 by the American Society for Microbiology. All rights reserved.